9:00 AM - 10:40 AM

[28PO1-am1-01S] Analysis of physicochemical features in drugs that induce hypoglycemia using JADER

○Kazuho Tanazawa¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

9:00 AM - 10:40 AM

[28PO1-am1-02S] Analysis of the association between DPP-4 inhibitor and angioedema using FAERS

○Junichiro Shindo¹, Katsuhiro Ohyama¹, Hiroyuki Tanaka², Yusuke Hori¹ (1. School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 2. Faculty of Pharmaceutical Sciences, Toho University)

9:00 AM - 10:40 AM

[28PO1-am1-03S] Development of prediction models to identify drugs causing renal injury using chemical structure information

○Yuki Sunaga¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

9:00 AM - 10:40 AM

[28PO1-am1-04S] Analysis of skin disorders in molecular-targeted drugs using JADER

○Koichiro Arashi¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

9:00 AM - 10:40 AM

[28PO1-am1-05S] Exploring biochemical pathways associated with disorders of consciousness by the JADER.

○Susumu Ninomiya¹, Yoshihiro Uesawa¹ (1. Meiji Pharm.Univ.)

9:00 AM - 10:40 AM

[28PO1-am1-06S] Classification of NSAIDs based on the reporting frequency of gastrointestinal adverse effects using JADER

○Naoaki Tahara¹, Yoshihiro Uesawa¹ (1. Meiji Pharma. Univ.)

9:00 AM - 10:40 AM

[28PO1-am1-07S] Risk analysis of drug-induced headache using the Japanese Adverse Drug Event Report database (JADER)

○Tsugumi Hirose¹, Maho Taguchi¹, Hiroaki Yamada¹ (1. Pharm.Yokohama Univ.)

9:00 AM - 10:40 AM

[28PO1-am1-08S] Development of machine learning models to predict patients who need adjustment of leftover drugs

○Sohma Miura¹, Takamasa Sakai¹, Hiroshi Sakata², Kouichi Tanabe¹, Fumiko Ohtsu¹ (1. Meijo univ pharma, 2. Kasugai municipal hosp)

9:00 AM - 10:40 AM

[28PO1-am1-09] A survey of aluminum compound adjuvents in vaccines used in Japan

○Misaki Akagawa¹, Mikie Yamato¹, Hirohisa Doi¹, Kenichi Chonan¹ (1. Showa Pharmaceutical Univ.)

9:00 AM - 10:40 AM

[28PO1-am1-10S] Needs analysis based on questionnaire results for participants in health counseling at drug stores

○Izumi Oki¹, Mei Tomiyasu¹, Hirotaka Suzuki², Azuma Yamamoto², Yuka Moriya¹, Akio Itoh¹, Shuichi Matsumoto¹, Yoichi Hasegawa¹, Shunsuke Kurono¹ (1. Fac. of Pharm. Meijo Univ. , 2. SugiyamaDrugs Co.Ltd.)

9:00 AM - 10:40 AM

[28PO1-am1-11S] Problems revealed by the results of a questionnaire survey on medication guidance for eye drops at insurance pharmacies

○Kenji Yamazaki¹, Masayuki Ishikawa¹, Yuko Sekine¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ)

9:00 AM - 10:40 AM

[28PO1-am1-12] Survey on how to take decoction

○Ryoko Ouchi¹, Yuma Nagano², Mamoru Maeda², MAsashi Ichinowatari², Sachiko Akagi², Yoshitaka Hasegawa², Ryota Tsukioka², Miya Oishi² (1. AIN Pharmacy IIZUKA,AIN PHARMACIEZ INC, 2. AIN HOLDINGS INC)

9:00 AM - 10:40 AM

[28PO1-am1-13S] Analysis of activities regarding “Yaku-Yaku” collaboration to improve the quality of outpatient cancer chemotherapy nationwide

○Fuma Nomura¹, Maho Taguchi¹, Masayuki Kaneta¹, Kiho Okuma¹, Hiroaki Yamada¹ (1. Yokohama Univ. Pharm.)

9:00 AM - 10:40 AM

[28PO1-am1-14] Comparison of perceptions between patients and pharmacists regarding medical services required of pharmacies

○Ayako IHARA¹, Taito Yamada¹, Nobue Hashimoto¹, Shizuka Yamazaki¹, Satoshi Yuge¹, Katsushi Fukuoka¹ (1. NIHONCHOUZAI)

9:00 AM - 10:40 AM

[28PO1-am1-15] Current status and issues of suicide prevention measures by insurance pharmacists in Gunma Prefecture

○Kazuya Hirano¹, Nobuyuki Doi¹, Yuki Kanai¹ (1. Takasaki University of Hearth and Welfare, Faculty of Pharmacy)

9:00 AM - 10:40 AM

[28PO1-am1-16] Evaluation of onset risk of dementia by drugs for treating overactive bladder

○Gaku Akashita¹, Akane Watanabe¹, Atsushi Yamato², Shun Kumagai², Eriko Nakatani¹, Mizuki Shiho¹, Takashi Okura¹ (1. Fac. Pharm-Sci., Teikyo Univ., 2. Sundrug)

9:00 AM - 10:40 AM

[28PO1-am1-17S] Survey on selection of renal function estimation formula according to patient condition to prevent overdose

○Misaki Miyazawa¹, Yoshiki Ueda¹, Takahito Sonobe¹, Miyoshi Kawakami¹, Yuji Yoshiyama¹, Toshimi Iizuka^1,2 (1. Kitasato University School of Pharmacy, 2. Bosei Pharmacy Co., Ltd.)

9:00 AM - 10:40 AM

[28PO1-am1-18] Effectiveness in medication guidance of phosphate binder for the patients with chronic kidney disease and the factors associated with the effectiveness

○Yasuharu Kashiwagura¹, Hiroshi Suzuki², Eno Tsuboi¹, Shimako Tanaka¹, Katsuya Yamauchi², Shinji Kageyama³, Noriyuki Namiki⁴, Shinya Uchida¹ (1. Sch. Pharm. Sci., Univ. Shizuoka , 2. Yamauchi Pharm. , 3. Kageyama Urol. Clinic, 4. Fac. Pharm. Sci., Teikyo Heisei Univ.)

9:00 AM - 10:40 AM

[28PO1-am1-19] Performance survey on question inquiry and prescription change based on clinical laboratory test values

○Ryo Hirano¹, Natumi Ihara¹, Hikaru Miyazaki¹, Takashi Nisigaki¹ (1. Qol pharmacy)

9:00 AM - 10:40 AM

[28PO1-am1-20] Inhalational instructions by community pharmacies (3rd report)
- In Ishikawa prefecture, about inhalational instructions evaluation of Temari Group 3 areas -

○Yoko Murai¹, Shinji Okamoto¹, Yachiyo Furukawa¹, Etsuyo Wada¹, Tamiko Shogen², Ayumi Okada³, Kou Sato⁴, Naohiro Sugita⁵, Masako Hashimoto⁶ (1. Temariwakunami Pharmacy, 2. Temarikobu Pharmacy, 3. Nakanotomachi Pharmacy, 4. Nomineagariekimae Branch Temari Pharmacy, 5. Drug Information Office Spatel Co., Ltd., 6. Spatel Co., Ltd.)

9:00 AM - 10:40 AM

[28PO1-am1-21S] Investigation of domestic taking medicine support tools of Japan

○Momoko Miyamae¹, Hirohisa Doi¹, Mikie Yamato¹, Kenichi Chonan¹ (1. Showa Pharmaceutical University. Education Research Center for Clinical Pharmacy.Pharmaceutical Information Department)

9:00 AM - 10:40 AM

[28PO1-am1-22S] Evaluation of impaired performance using psychomotor function tests in patients taking antihistamines

○Rihoko Karashima¹, Tomomi Uno¹, Akitaka Murata^1,2, Genta Hazitsu³, Toru Takeuchi³, Mikio Sakakibara⁴, Yasunori Yamada⁵, Mitsuru Saguchi⁵, Manako Hanya¹, Hiroyuki Kamei¹ (1. Meijo Univ., 2. V drug sohara, 3. Pinokio Pharmacy , 4. Sugi Pharmacy , 5. Chubuyakuhin Co.,Ltd, medical division)

9:00 AM - 10:40 AM

[28PO1-am1-23] Effects of family pharmacists on the adherence of hypertensive patients

○Mai Uemura¹, Ryoto Mashiko¹, Ema Sato², Yuma Nagano³, Mamoru Maeda³, Sachiko Akagi³, Yoshitaka Hasegawa³, Ryota Tsukioka³, Miya Oishi³ (1. AIN Pharmacy HOSHIGAURA, AIN PHARMACIEZ INC., 2. AIN PHARMACIEZ INC., 3. AIN HOLDINGS INC.)

9:00 AM - 10:40 AM

[28PO1-am1-24S] A Survey on the Current Status and Ideals of Pharmacists in Home Health Care: The Influence of City Size on the Relationships with Multiple Professions, Patients and Families

○Motoko Yasuda¹, Haruka Usui², Taro Kushihata², Masahiro Ueda², Tomohisa Yasuhara³, Misa Nagata³, Atsushi Kinoshita¹, Takahiro Fujimoto⁴, Keiichi Miyake⁴, Syuichi Kasai⁴, Tomomichi Sone² (1. Sch. Pharm. Hyogo Univ. Health Sci., 2. Fac. Pharm. Setsunan Univ., 3. Wakayama Med. Univ., 4. Hyogo Pharmaceutical Association)

9:00 AM - 10:40 AM

[28PO1-am1-25S] A Survey on the Current Status and Ideals of Pharmacists in Home Health Care: The Influence of City Size on Perceptions of Present Situation and Stress

○Haruka Usui¹, Motoko Yasuda², Taro Kushihata¹, Masahiro Ueda¹, Tomohisa Yasuhara³, Misa Nagata³, Atsushi Kinoshita², Takahiro Fujimoto⁴, Keiichi Miyake⁴, Syuichi Kasai⁴, Tomomichi Sone¹ (1. Fac. Pharm. Sci., Setsunan Univ., 2. Sch. of Pharm, Hyogo Univ. Health. Sci , 3. Wakayama Med. Univ.,, 4. Hyogo Pharmaceutical Association)

9:00 AM - 10:40 AM

[28PO1-am1-26] A case that took of the advantage of the expertise of pharmacists to end-of-life care at home cancer patient in the COVID-19 pandemic

○Yoko Takeshita¹, Tika Sugiura¹, Yurie Fukuyama¹, Yasuhiro Hosokawa² (1. Kraft Inc. Sakura Parmacy, 2. Kraft Inc.)

9:00 AM - 10:40 AM

[28PO1-am1-27] The role of community pharmacies in home healthcare

○Kazuki Kushida¹, Takeya Shiraishi², Hirofumi Imajyou³, Hiromu Tanigawa^1,4, Masayoshi Hirohara¹, Seiko Miyazaki¹ (1. Showa Pharmaceutical University, 2. Keyaki Pharmacy, 3. Tsumashina Pharmacy, 4. Division of Pharmacy, Tokai University Medical Hospital)

9:00 AM - 10:40 AM

[28PO1-am1-28S] A case–control study of screening the concomitant drugs that affect the effectiveness of oral anticoagulants

○Natsuko Goto¹, Yohei Kawano¹, Ayako Maeda¹, Tatsunori Suzuki¹, Yasunari Mano¹, Takao Aoyama¹ (1. Pharm. Sci., Tokyo Univ. Sci.)

9:00 AM - 10:40 AM

[28PO1-am1-29] Survey on the actual use of anticoagulant antagonists in our hospital

○Riho Murai¹, Shintaro Akiyama¹, Masanori Suzuki^1,2, Ryohkan Funakoshi^1,3 (1. Department of Pharmacy, Kameda Medical Center, 2. Postgraduate center, Kameda Medical Center, 3. Pharmaceutical Management Department, Kameda Medical Center)

9:00 AM - 10:40 AM

[28PO1-am1-30] Influence of cyclosporin concentration on OATP1B activity using coproporphyrin-I

○Takuma Watanabe¹, Ryota Tanaka¹, Yosuke Suzuki², Hiroyuki Ono¹, Haruki Sato², Jun Negami², Chisato Yoshijima², Ayako Oda², Ryosuke Tatsuta¹, Keiko Ohno², Hiroki Itoh¹ (1. Dept. of Clin. Pharm., Oita Univ. Hosp., 2. Dept. of Med. Use Anal. and Clin. Res., Meiji Pharm. Univ.)

9:00 AM - 10:40 AM

[28PO1-am1-31S] Interraction of colistin and sevoflurane on neuromuscular blocking effects

○Mai Gotoda¹, Shino Shishido¹, Yuki Enoki¹, Kazuaki Taguchi¹, Kazuaki Matsumoto¹ (1. Keio Univ., Fac. Pharm.)

9:00 AM - 10:40 AM

[28PO1-am1-32S] Effects of enteral nutrition and protein content on the pharmacokinetics of valproic acid in rats

○Takumi Kawamura¹, Yoko Urashima¹, Yuya Otsuka¹, Kazuya Urashima², Kaoru Suzuki³, Kazumi Kurachi³, Masami Nishihara³, Masashi Neo³, Takuro Kobori¹, Tokio Obata¹ (1. Facult. Pharm., Osaka Ohtani Univ., 2. Dept. Pharm., JCHO Hoshigaoka Med. Ctr., 3. Dept. Pharm., Osaka Med. Pharm. Univ. Hosp.)

9:00 AM - 10:40 AM

[28PO1-am1-33S] Stability of rifampicin in the standard treatment of tuberculosis using a simple suspension method

○Nana Yokoyama¹, Yoshinori Tomoda¹, Masahiro Kobayashi¹ (1. Kitasato Univ.)

9:00 AM - 10:40 AM

[28PO1-am1-34S] Appearance and fibril morphology of insulin formulations in high temperature environment

○Taiyo Nakazawa¹, Toshinari Asakura¹, Shinichi Asada¹ (1. Facult. of Pharm. Sci., NUPALS, Japan)

9:00 AM - 10:40 AM

[28PO1-am1-35S] Development of drug non-adsorbent infusion line by coating with high molecular polymer
-Examination from insulin adsorption-

○Tsubasa Koike¹, Shouta Kondo¹, Yohei Kawano¹, Takao Aoyama¹ (1. Pharm. Sci., Tokyo Univ. Sci.)

9:00 AM - 10:40 AM

[28PO1-am1-36S] Study on permeability of antineoplastic agents to medical gloves
-Analysis of factors affecting permeability-

○Reina Kumatani¹, Yohei Kawano¹, Toyohito Oriyama², Takehito Yamamoto^2,3, Hiroshi Suzuki², Takao Aoyama¹ (1. Pharm. Sci., Tokyo Univ. Sci., 2. Dep. Pharm, Tokyo Hosp., 3. Pharm. Sci., Tokyo Uni.)

9:00 AM - 10:40 AM

[28PO1-am1-37] Impact of CYP3A5 and CYP2J2 polymorphisms on trough plasma concentration in atrial fibrillation patients taking low-dose rivaroxaban or apixaban

○Naoya Aiuchi¹, Junichi Nakagawa¹, Takahiko Kinjo², Kayo Ueno¹, Hirofumi Tomita², Takenori Niioka¹ (1. Department of Pharmacy, Hirosaki Univ. Hospital , 2. Department of Cardiology, Hirsaoki Univ. Grad. School of Medicine)

9:00 AM - 10:40 AM

[28PO1-am1-38S] An analysis of relationship between chemotherapy-induced gastrointestinal symptoms and polymorphism

○Rika Uchino¹, Mariko Nakamura¹, Akira Yoshimi^1,2,3, Aya Torii^1,4, Masayuki Miyazaki^1,3, Kiyofumi Yamada³, Yukihiro Noda^1,2,3 (1. Fac and Grad Sch Pharm, Meijo Univ, 2. Clin OMICs and Trans Res Cent, Meijo Univ, 3. Nagoya Univ Hosp Pharm, 4. Fac Pharm, Kinjo Univ)

9:00 AM - 10:40 AM

[28PO1-am1-39S] Effect of the SLC5A2 polymorphism on the hypoglycemic and weight loss effects of SGLT2 inhibitors

○Kanon Sakai¹, Ayami Morita², Kentaro Oniki¹, Yuki Sakamoto¹, Ami Kondo¹, Moeka Matsuo¹, Akari Maruyama¹, Akira Yoshida², Hiroyuki Nishimura², Yuki Shioyama², Masafumi Takada², Hiroko Ijima², Fumio Miyamoto², Seigo Sugiyama², Kunio Hieshima², Noboru Kuriyama², Keizo Kajiwara², Katsunori Jinnouchi², Tomio Jinnouchi², Hideaki Jinnouchi², Junji Saruwatari¹ (1. Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Jinnouchi Hospital)

9:00 AM - 10:40 AM

[28PO1-am1-40] Examination of comparison between glimepiride tablets and glimepiride OD tablets

○Satoshi Okumura¹, Chieko Maida¹, Shigeo Akiyama², Etsuko Miyamoto³, Yoshifumi Murata¹ (1. Fac. Pharm. Sci., Hokuriku Univ., 2. Tokyo Univ. Pharm. & Life Sci., 3. NPO HEART)

9:00 AM - 10:40 AM

[28PO1-am1-41S] Fact-Finding Survey to Promote the Use of Generic Drug Loxoprofen-Sodium Tape in Kyoto Prefecture

○Akane Nishida¹, Nobuhiko Nakamura¹, Tamotsu Nakabayashi², Masaaki Kusumoto^1,2 (1. Kyoto Pharmaceutical University, 2. Kyoto Pharmaceutical Association)

9:00 AM - 10:40 AM

[28PO1-am1-42] Comparison of Original and Generic Lamivudine-Abacavir Sulfate Combination Tablets in Applicability of the Simple Suspension Method

○Misako Matsukawa¹, Hiroki Yagura², Yoshinori Yanagisawa¹, Yuko Nakayama¹, Reiko Teraoka¹ (1. Himeji Dokkyo Univ., 2. Osaka National Hospital)

9:00 AM - 10:40 AM

[28PO1-am1-43] Comparative study of salazosulfapyridine enteric-coated tablets brand-name and generic drugs by dissolution test

○Nanase Goya¹, Atsuya Murakami¹, Chieko Maida¹, Shigeo Akiyama², Etsuko Miyamoto³, Yoshifumi Murata¹ (1. Fac. Pharm. Sci., Hokuriku Univ., 2. Tokyo Univ. Pharm. & Life Sci., 3. NPO HEART)

9:00 AM - 10:40 AM

[28PO1-am1-44S] Study on the costs of managing adverse drug events in the patients admitted to the department of psychiatry

○Satoaki Kubo¹, Tomoya Tachi^1,2, Keisuke Aoyama¹, Aisa Koyama¹, Mayuko Watanabe², Satoshi Aoyama², Yoshihiro Noguchi¹, Kazuhide Tanaka², Masahiro Yasuda², Akihiko Shibata³, Takashi Mizui², Hitomi Teramachi¹ (1. Gifu Pharmaceutical Univ., 2. Department of Pharmacy, Gifu Municipal Hospital, 3. Department of Psychiatry, Gifu Municipal Hospital)

9:00 AM - 10:40 AM

[28PO1-am1-45S] Investigation into the effect of optical isomers on drug–drug interactions using a spontaneous adverse drug reaction reporting database.

○Mami Neishi¹, Hirofumi Hamano², Takahiro Niimura², Koji Miyata², Kenta Yagi², Mitsuhiro Goda³, Yoshito Zamami⁴, Keisuke Ishizawa^2,3, Hideki Nawa¹ (1. Department of Pharmacy, Faculty of Pharmacy, Shujitsu University, 1-6-1 Nishigawara, Nakaku, Okayama, Japan, 2. Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Kuramoto, Tokushima, Japan, 3. Department of Pharmacy, Tokushima University Hospital, Kuramoto, Tokushima, Japan, 4. Department of Pharmacy, Okayama University Hospital, Kita-ku Shikatatyou2-5-1, Okayama, Japan)

9:00 AM - 10:40 AM

[28PO1-am1-46] Association between antifibrotic drugs and interstitial lung disease using a spontaneous adverse drug reaction reporting database.

○oonisi asuka¹, nawa hideki¹, hirofumi hamano², Takahiro Niimura², Koji Miyata², Kenta Yagi³, Mitsuhiro Goda³, Yoshito Zamami⁴, Keisuke Ishizawa^2,3 (1. Department of Pharmacy, Faculty of Pharmacy, Shujitsu University, 2. Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Kuramoto, Tokushima, Japan, 3. Department of Pharmacy, Tokushima University Hospital, Kuramoto, Tokushima, Japan, 4. Department of Pharmacy, okayama University Hospital, naka-ku sikatatyou2-5-1, okayama, Japan)

9:00 AM - 10:40 AM

[28PO1-am1-47] The contribution of pharmacists to the establishment of a safe and appropriate COVID-19 vaccination system - approaches in prior vaccination for healthcare workers -

○Junko Inaba¹, Yuko Fukuda¹, Fumiaki Kitazawa¹, Masahiko Tsujikawa¹ (1. Department of Pharmacy, JCHO Hoshigaoka Medical Center)

9:00 AM - 10:40 AM

[28PO1-am1-48] Exploring psychological factors related to preventive behaviors of university students during the COVID-19 pandemic.

○Junya Mikata¹, Shinji Oshima¹, Norimitsu Horii^1,2, Akira Yoshida¹, Naohito Takahashi¹, Mizue Mutoh¹, Naoko Inoue^1,2, Sachihiko Numajiri¹, Shigeru Ohshima^1,2, Daisuke Kobayashi^1,2 (1. Grad. Sch. Pharm. Sci., Josai Univ., 2. Josai university pharmacy)

9:00 AM - 10:40 AM

[28PO1-am1-49] Association of ROS-mediated Beclin-1 suppression and mitochondrial dysfunction in daptomycin-induced skeletal muscle toxicity

○Yuki Enoki¹, Kazuaki Taguchi¹, Kazuaki Matsumoto¹ (1. Keio Univ., Fac. Pharm.)

9:00 AM - 10:40 AM

[28PO1-am1-50S] Relationship between chronotype and daily fluctuations of blood glucose trend value in healthy people

○Mimine Okasaka¹, Yuria Kato¹, Ayaka Matsunaga¹, Manami Hiruta¹, Hideko Kitamura², Jyunnko Ito³, Aya Torii^1,2, Masae Yoshikawa^1,2 (1. Kinjo Gakuin Univ., 2. cure pharma, 3. Ito naika clinic)

9:00 AM - 10:40 AM

[28PO1-am1-51S] A study on communication evaluation methods 1: Effects on EEG and ECG in each emotion

○Rana Suzuki¹, Yu Sakuma¹, Yukina Miyagi^1,3, Yuka Miyachi¹, Saori Gocho^1,3,4, Chika Nakayama², Taeyuki Oshima¹ (1. College of Pharmacy, Kinjo Gakuin University, 2. Faculty of Pharmacy, Gifu University of Medical Science, 3. Graduate School of Medicine, Aichi Medical University, 4. Department of Pharmacy, Nagoya Ekisaikai Hospital)

9:00 AM - 10:40 AM

[28PO1-am1-52] Relationship between tracheal intubation and the drugs used by patients with drug overdose due to self-harm

○Kazuki Nagashima¹, Hiroyuki Hosono¹, Machiko Watanabe¹ (1. Fac. of Pharma-Science, Teikyo Univ.)

9:00 AM - 10:40 AM

[28PO1-am1-53S] Column-switching HPLC detection method for malic acid enantiomers in commercial wines

○Ryuji Kanda¹, Mayu Onozato¹, Yushi Sato¹, Tatsuya Sakamoto¹, Maho Umino¹, Takeshi Fukushima¹ (1. Pharm. Sci., Toho Univ.)

Session information

[28PO1-am1] Drug information-4/Community pharmacy, home medical care, and community health care-3/Appropriate use of medicines (drug-drug interactions)-2/Pharmacotherapies (Personalized therapies)/Generic medicines/Others

Authentication